Mariko Suetsugu

904 total citations
24 papers, 700 citations indexed

About

Mariko Suetsugu is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Molecular Biology. According to data from OpenAlex, Mariko Suetsugu has authored 24 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Mariko Suetsugu's work include Adipokines, Inflammation, and Metabolic Diseases (7 papers), Diabetes Treatment and Management (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Mariko Suetsugu is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (7 papers), Diabetes Treatment and Management (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Mariko Suetsugu collaborates with scholars based in Japan. Mariko Suetsugu's co-authors include Kohzo Takebayashi, Toshihiko Inukai, Yoshimasa Aso, Sadao Wakabayashi, Kenji Hara, Kimio Morita, Sachiko Matsumoto, Rika Matsutomo, Takafumi Tsuchiya and S. Wakabayashi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Metabolism and Diabetic Medicine.

In The Last Decade

Mariko Suetsugu

23 papers receiving 676 citations

Peers

Countries citing papers authored by Mariko Suetsugu

Since Specialization

Citations

This map shows the geographic impact of Mariko Suetsugu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mariko Suetsugu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mariko Suetsugu more than expected).

Fields of papers citing papers by Mariko Suetsugu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mariko Suetsugu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mariko Suetsugu. The network helps show where Mariko Suetsugu may publish in the future.

Co-authorship network of co-authors of Mariko Suetsugu

This figure shows the co-authorship network connecting the top 25 collaborators of Mariko Suetsugu. A scholar is included among the top collaborators of Mariko Suetsugu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mariko Suetsugu. Mariko Suetsugu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Effect of Alogliptin on Glycemic Control in Japanese Patients With Type 2 Diabetes: A 3.5-Year Observational Study 2017 ·Journal of Clinical Medicine Research ·Kohzo Takebayashi, (unknown), (unknown), Kenji Hara, Mariko Suetsugu, Takafumi Tsuchiya, Toshihiko Inukai	6
2	The Effect of Switching from Either Mitiglinide or Glimepiride to Repaglinide on Both Glycemic Control and Oxidative Stress in Patients with Type 2 Diabetes 2016 ·Toshihiko Inukai, Kohzo Takebayashi, (unknown), (unknown), Kenji Hara, Mariko Suetsugu, (unknown)	1
3	Circulating SerpinB1 levels and clinical features in patients with type 2 diabetes 2016 ·BMJ Open Diabetes Research & Care ·Kohzo Takebayashi, Kenji Hara, (unknown), (unknown), Mariko Suetsugu, Takafumi Tsuchiya, Toshihiko Inukai	14
4	Long Term Evaluation of Glycemic Control in Patients with Type 2 Diabetes Receiving Either Alogliptin and Lansoprazole or Alogliptin Mono-therapy for 3 Months Followed by Alogliptin Mono-therapy:A Retrospective Analysis 2015 ·Kohzo Takebayashi, (unknown), (unknown), Kenji Hara, Mariko Suetsugu, Takafumi Tsuchiya, Toshihiko Inukai	4
5	Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients 2014 ·Obesity Research & Clinical Practice ·(unknown), (unknown), (unknown), Kenji Hara, Mariko Suetsugu, Kohzo Takebayashi, Kimio Morita, Yoshimasa Aso, Toshihiko Inukai	8
6	Oxidative stress and antioxidative potency are closely associated with diabetic retinopathy and nephropathy in patients with type 2 diabetes. 2013 ·PubMed ·(unknown), Mariko Suetsugu, (unknown), (unknown), Kenji Hara, Kohzo Takebayashi, Kimio Morita, Yoshimasa Aso, Toshihiko Inukai	31
7	Serum level of soluble CD26/dipeptidyl peptidase-4 (DPP-4) predicts the response to sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes controlled inadequately by metformin and/or sulfonylurea 2011 ·Translational research ·Yoshimasa Aso, (unknown), (unknown), (unknown), Kenji Hara, Mariko Suetsugu, Kohzo Takebayashi, (unknown), (unknown), Kimio Morita, Toshihiko Inukai	66
8	Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review 2011 ·Journal of Viral Hepatitis ·Takumi Kawaguchi, Tatsuya Ide, Minoru Itou, Mariko Suetsugu, Shinichiro Yoshioka, Masahiro Sakata, Eitaro Taniguchi, Tetsuharu Oriishi, Shuji Sumie, O. Tsuruta, M Sata	3
9	Relation between serum high molecular weight adiponectin and serum ferritin or prohepcidin in patients with type 2 diabetes 2010 ·Diabetes Research and Clinical Practice ·Yoshimasa Aso, Kohzo Takebayashi, Sadao Wakabayashi, (unknown), (unknown), (unknown), (unknown), Kenji Hara, Mariko Suetsugu, Kimio Morita, Toshihiko Inukai	38
10	Anemia is associated with an elevated serum level of high-molecular-weight adiponectin in patients with type 2 diabetes independently of renal dysfunction 2009 ·Translational research ·Yoshimasa Aso, (unknown), Sadao Wakabayashi, Kenji Hara, (unknown), Mariko Suetsugu, Sachiko Matsumoto, (unknown), Kohzo Takebayashi, Kimio Morita, Toshihiko Inukai	26
11	Serum high–molecular weight adiponectin decreases abruptly after an oral glucose load in subjects with normal glucose tolerance or impaired fasting glucose, but not those with impaired glucose tolerance or diabetes mellitus 2009 ·Metabolism ·(unknown), Kenji Hara, (unknown), (unknown), Sachiko Matsumoto, Mariko Suetsugu, (unknown), Kohzo Takebayashi, Toshihiko Inukai, (unknown), Yoshimasa Aso	18
12	Low-dose pioglitazone increases serum high molecular weight adiponectin and improves glycemic control in Japanese patients with poorly controlled type 2 diabetes 2009 ·Diabetes Research and Clinical Practice ·Yoshimasa Aso, Kenji Hara, (unknown), (unknown), (unknown), Sachiko Matsumoto, Mariko Suetsugu, (unknown), Kohzo Takebayashi, (unknown), Toshihiko Inukai	23
13	Effects of Rosuvastatin and Colestimide on Metabolic Parameters and Urinary Monocyte Chemoattractant Protein-1 in Type 2 Diabetic Patients with Hyperlipidemia 2009 ·Southern Medical Journal ·Kohzo Takebayashi, Mariko Suetsugu, Sachiko Matsumoto, Yoshimasa Aso, Toshihiko Inukai	20
14	Comparison of the effects of pioglitazone and voglibose on circulating total and high‐molecular‐weight adiponectin, and on two fibrinolysis inhibitors, in patients with Type 2 diabetes 2007 ·Diabetic Medicine ·Yoshimasa Aso, Ruriko Yamamoto, Mariko Suetsugu, Sachiko Matsumoto, S. Wakabayashi, Rika Matsutomo, Kohzo Takebayashi, Toshihiko Inukai	22
15	Association between diabetic microangiopathy and vascular endothelial function evaluated by flow-mediated vasodilatation in patients with type 2 diabetes 2007 ·International Journal of Clinical Practice ·Mariko Suetsugu, Kohzo Takebayashi, Yoshimasa Aso	22
16	Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus 2007 ·Metabolism ·Kohzo Takebayashi, Mariko Suetsugu, Sadao Wakabayashi, Yoshimasa Aso, Toshihiko Inukai	148
17	Retinol Binding Protein-4 Levels and Clinical Features of Type 2 Diabetes Patients 2007 ·The Journal of Clinical Endocrinology & Metabolism ·Kohzo Takebayashi, Mariko Suetsugu, Sadao Wakabayashi, Yoshimasa Aso, Toshihiko Inukai	176
18	Correlation of High-sensitivity C-reactive Protein and Plasma Fibrinogen with Individual Complications in Patients with Type 2 Diabetes 2006 ·Southern Medical Journal ·Kohzo Takebayashi, Mariko Suetsugu, Rika Matsutomo, Sadao Wakabayashi, Yoshimasa Aso, Toshihiko Inukai	17
19	Relationships between Heart Rate Variability and Urinary Albumin Excretion in Patients with Type 2 Diabetes 2006 ·The American Journal of the Medical Sciences ·Kohzo Takebayashi, Rika Matsutomo, Sachiko Matsumoto, Mariko Suetsugu, Sadao Wakabayashi, Yoshimasa Aso, Toshihiko Inukai	4
20	Small low-density lipoprotein and small low-density lipoprotein/total low-density lipoprotein are closely associated with intima-media thickness of the carotid artery in Type 2 diabetic patients 2005 ·Journal of Diabetes and its Complications ·Toshihiko Inukai, Ruriko Yamamoto, Mariko Suetsugu, Sachiko Matsumoto, S. Wakabayashi, Y. Inukai, Rika Matsutomo, Kohzo Takebayashi, Yoshimasa Aso	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact